tiprankstipranks
Trending News
More News >
Purple Biotech (PPBT)
NASDAQ:PPBT
US Market

Purple Biotech (PPBT) Financial Statements

Compare
1,107 Followers

Purple Biotech Financial Overview

Purple Biotech's market cap is currently $6.50M. The company's EPS TTM is $-0.29; its P/E ratio is -0.62; Purple Biotech is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is $-0.34. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 195.80K$ 0.00$ 0.00$ 1.00M
Gross Profit$ -186.00K$ -196.00$ -120.00$ -55.00$ 999.94K
Operating Income$ -11.01M$ -22.27M$ -22.60M$ -17.93M$ -13.24M
EBITDA$ -7.05M$ -19.88M$ -21.49M$ -17.52M$ -28.41M
Net Income$ -7.24M$ -19.88K$ -21.67M$ -18.38M$ -28.00M
Balance Sheet
Cash & Short-Term Investments$ 8.52M$ 15.41M$ 32.11M$ 47.20M$ 57.80M
Total Assets$ 37.04M$ 44.30M$ 54.62M$ 70.20M$ 83.80M
Total Debt$ 183.00K$ 351.00K$ 515.00K$ 749.00K$ 895.00K
Net Debt$ -7.22M$ -14.14M$ -14.52M$ -10.14M$ -10.35M
Total Liabilities$ 4.13M$ 10.01M$ 7.52M$ 5.09M$ 4.05M
Stockholders' Equity$ 32.86M$ 34.21M$ 46.91M$ 64.83M$ 79.39M
Cash Flow
Free Cash Flow$ -14.37M$ -19.93M$ -16.96M$ -15.19M$ -12.25M
Operating Cash Flow$ -14.37M$ -19.93M$ -16.73M$ -15.07M$ -12.09M
Investing Cash Flow$ 509.00K$ 13.88M$ 19.91M$ 13.41M$ -49.59M
Financing Cash Flow$ 6.77M$ 5.45M$ 1.11M$ 1.51M$ 68.49M
Currency in USD

Purple Biotech Earnings and Revenue History

Purple Biotech Debt to Assets

Purple Biotech Cash Flow

Purple Biotech Forecast EPS vs Actual EPS